Literature DB >> 15286386

Animal models for autoimmune myocarditis and autoimmune thyroiditis.

Daniela Ciháková1, Rajni B Sharma, DeLisa Fairweather, Marina Afanasyeva, Noel R Rose.   

Abstract

This chapter describes four murine models of autoimmune diseases: two related to autoimmune myocarditis and two related to autoimmune thyroiditis. The first model, Coxsackie virus B3 (CB3)-induced myocarditis, results in the development of acute myocarditis in susceptible as well as resistant mouse strains, whereas chronic myocarditis develops only in genetically susceptible mice. CB3-induced myocarditis closely resembles the course of human myocarditis, which is believed to be initiated by viral infection. Mouse cardiac myosin heavy chain has been identified as the major antigen associated with the late chronic phase of viral myocarditis. The second model is cardiac myosin-induced experimental autoimmune myocarditis (EAM) and, in a modification, cardiac alpha-myosin heavy chain peptide-induced myocarditis. In the EAM model, cardiac myosin or the relevant peptide in Freund's complete adjuvant (FCA) is injected subcutaneously into mice. The immune response, the histological changes, and the genetic susceptibility seen in EAM are similar to those of CB3-induced myocarditis. The third model is experimental autoimmune thyroiditis (EAT). EAT can be induced in genetically susceptible strains of mice by immunization with mouse thyroglobulin in FCA or lipopolysaccharide. Mice susceptible to EAT have the H-2A(k), H-2A(s), or H-2A(q) alleles. We describe here a standard technique for the induction of EAT; it was developed in our laboratory and is widely used as a model for studying Hashimoto's thyroiditis. The fourth model presented in this chapter is that of spontaneous autoimmune thyroiditis in NOD.H2h4 mice. These mice express the H-2A(k) allele on an NOD genetic background and develop spontaneous thyroiditis, which is exacerbated with dietary iodine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15286386     DOI: 10.1385/1-59259-805-6:175

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  39 in total

1.  Macrophages participate in IL-17-mediated inflammation.

Authors:  Jobert G Barin; G Christian Baldeviano; Monica V Talor; Lei Wu; Sufey Ong; Farhan Quader; Ping Chen; Dongfeng Zheng; Patrizio Caturegli; Noel R Rose; Daniela Ciháková
Journal:  Eur J Immunol       Date:  2012-01-23       Impact factor: 5.532

Review 2.  Animal models of human type 1 diabetes.

Authors:  Matthias von Herrath; Gerald T Nepom
Journal:  Nat Immunol       Date:  2009-02       Impact factor: 25.606

3.  Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response.

Authors:  Lianhua Yan; Fen Hu; Xiaofei Yan; Yuzhen Wei; Wenhan Ma; Ya Wang; Shuai Lu; Zhaohui Wang
Journal:  J Mol Med (Berl)       Date:  2016-04-06       Impact factor: 4.599

Review 4.  Macrophage diversity in cardiac inflammation: a review.

Authors:  Jobert G Barin; Noel R Rose; Daniela Ciháková
Journal:  Immunobiology       Date:  2011-06-30       Impact factor: 3.144

Review 5.  Cardiac Autoimmunity: Myocarditis.

Authors:  William Bracamonte-Baran; Daniela Čiháková
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

6.  Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.

Authors:  Jobert G Barin; G Christian Baldeviano; Monica V Talor; Lei Wu; SuFey Ong; DeLisa Fairweather; Djahida Bedja; Natalie R Stickel; Jillian A Fontes; Ashley B Cardamone; Dongfeng Zheng; Kathleen L Gabrielson; Noel R Rose; Daniela Ciháková
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

Review 7.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

8.  A locus on chromosome 1 promotes susceptibility of experimental autoimmune myocarditis and lymphocyte cell death.

Authors:  Davinna L Ligons; Mehmet L Guler; Haiyan S Li; Noel R Rose
Journal:  Clin Immunol       Date:  2008-10-31       Impact factor: 3.969

9.  Republished: pathogenesis and diagnosis of myocarditis.

Authors:  Chantal Elamm; Delisa Fairweather; Leslie T Cooper
Journal:  Postgrad Med J       Date:  2012-09       Impact factor: 2.401

10.  Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside.

Authors:  Damien Bresson; Matthias von Herrath
Journal:  Diabetes Care       Date:  2009-10       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.